Is the iShares S&P 500 ETF (IVV) still a brilliant buy after storming higher?
Should investors still buy this fund or is it too expensive? The post Is the iShares S&P 500 ETF (IVV) still a brilliant buy ...
Paul Tudor Jones' Strategic Moves: A Closer Look at ISHARES BITCOIN TR
The most notable increase was ISHARES BITCOIN TR (NASDAQ:IBIT), with an additional 3,620,322 shares, bringing the total to 8,048,552 shares. This adjustment represents a significant 81.76% increase in ...
UPGD: For Now, No Meaningful Achievements With The New Strategy
After the strategy change in March 2024, UPGD tracks the Bloomberg ANR Improvers Index. Click here to read why Hold rating ...
OAKM: Quality And Value Heavy Large-Cap ETF, Worth Monitoring
OAKM has had a racy start as it has outsmarted IVV and a few value-heavy peers. Read why conservative Hold rating fits OAKM ...
Nasdaq4d
Detailed Fundamental Analysis - IVV
Below is Validea's ETF fundamental report for iShares Core S&P 500 Index Fund ETF (IVV). The report looks at IVV's exposure to the major investing factors including value, quality, momentum and ...
Soros buys Arthur J. Gallagher, boosts Accenture in Q4
George Soros’ Soros Fund Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund’s new buys during the fourth ...
Kathleen S. Wright Associates Inc. Boosts Position in iShares Core S&P 500 ETF (NYSEARCA:IVV)
Kathleen S. Wright Associates Inc. grew its holdings in shares of iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) by ...
iShares Core S&P 500 ETF (NYSEARCA:IVV) Holdings Lifted by Tandem Capital Management Corp ADV
Tandem Capital Management Corp ADV increased its holdings in iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) by 2.5% in ...
How I'd unlock more passive income from the iShares S&P 500 ETF (IVV)
The iShares S&P 500 ETF (ASX: IVV) has delivered very strong capital growth returns. Here’s how I’d unlock passive income.
Jeremy Grantham's Strategic Moves: A Closer Look at Thermo Fisher Scientific Inc.
The most notable increase was Thermo Fisher Scientific Inc (NYSE:TMO), with an additional 639,467 shares, bringing the total to 1,093,866 shares. This adjustment represents a significant 140.73% ...